Diagnostic & Monitoring

Diagnostic & Monitoring Solutions

From pre-diagnosis to screening and continuous monitoring.
A diagnostic and monitoring solution based on neuromuscular biosignals.

Maximize Your Practice Potential with exoRehab

RTM for MSK Rehabilitation with Reimbursement

Remote Therapeutic Monitoring (RTM)

FDA Registered

CES 2026 Innovation Award 「Digital Health 」Honoree

Why exoRehab?

RTM Solution in Combination with Digital Biomarker Technology
to Boost Recovery and Reimbursement

physician-consulting-with-his-staff-to-a

Medical Professional

Ⅴ Real-Time Remote Monitoring

Ⅴ Reimbursement-Ready

Ⅴ Muscle Health Monitoring*

* exoRehab-Pro

diverse-female-physiotherapist-and-senior-male-pat-2023-11-27-05-26-17-utc_edited.jpg

MSK Patients

Ⅴ Optimized for Effective MSK Recovery
Ⅴ Less visit to Hospital and Clinic
Ⅴ Quantitative MSK Monitoring*

* exoRehab-Pro

Remote Therapeutic Monitoring
Powered by Wearables

Prescribed exercises available on mobile application
compatible on AOS and iOS platforms.

Competitive Feature

Wearable Sensor for Digital Biomarker Collection

Digital biomarker collection via wearable sensor enabling better therapy response and compliance tracking for MSK patients by medical professional.

Web-based Patient Monitoring Tool

Allowing medical professionals to easily browse
MSK health status of multiple patients via web platform.

Expediting medical decision making process
with AI analysis of MSK digital biomarker data*

*collected from wearable sensor.

Patient Engagement

Real-time chat and reminder with patient to enhance
exercise therapy adherence and responses.

Solution Features

RTM Reimbursement

$ 19.38

Initial Setup

$ 55.72

First 20 Minutes

$ 50.18

Device
Monitoring

$ 40.84

Additional
20 Minutes

*national reimbursement average

Maximize Your Practice Potential with exoRehab

Free Trial Now

FDA Registered

Dynamic EMG

The postoperative recovery journey, shared by clinicians and patients.

exoPill dEMG

Rehabilitation progress demonstrated through data, not just words.
By comparing the affected and unaffected sides,

we build patient trust through objective evidence.

Generated Image November 19, 2025 - 5_07PM_edited.jpg

Recognized

Non-Reimbursable Service

We have received official notification from the Health Insurance Review & Assessment Service (HIRA) confirming recognition as a non-reimbursable medical service.

Code: EZ 773

Dynamic EMG for Motion Analysis

STANDARD SIDE

Healthy

Patient-specific baseline reference data

Recovery Monitoring

Data-Driven Rehabilitation Progress:

Patients Reassured, Clinicians Confident

For postoperative patients, nothing reassures more than seeing today’s data move closer to the healthy side—more than simply hearing

“You are recovering well.”

RECOVERY SIDE

Lesion

Stepwise recovery measurement of the surgical site

Recovery Indicator: Ratio of Affected to Unaffected Side

What matters more than muscle contraction strength is how closely the affected side resembles the healthy side. exoPill dEMG calculates the recovery rate of the affected side relative to the healthy side as a ratio, allowing clinicians and patients to review the same objective data during consultations.

Real-Time Comparison of Affected vs. Unaffected Side

Recovery Trend Reports by Rehabilitation Stage

Tracking Recovery Through Movement Onset Timing Comparison

Reports Patients Can Instantly Understand

This is a sample report, ideal for face-to-face discussions with patients.

1. Summary Report

With just a single left-right balance (Ratio) value, patients can instantly understand their own condition.

2. Detailed Waveform Comparison

Overlapping pre- and post-surgery waveforms visually demonstrate rehabilitation progress and outcomes.

3. Reaction Time Analysis

Subtle differences in reaction speed are quantified, enhancing confidence in the recovery process.

Verify the Recovery Together

Enhance clinical expertise and patient satisfaction with exoPill dEMG.
Our professional consultants provide guidance on hospital-optimized implementation and reimbursement support.

Sarcopenia Diagnostic Support Solution

EXOMED-DeepSARC

Sarcopenia Diagnosis Support Solution

Using AI digital biomarker technology that analyzes neuromuscular biosignals,the sarcopenia diagnostic process can be completed in approximately three minutes.

Generated Image January 21, 2026 - 6_40PM_edited.jpg

Sarcopenia increases the risk of falls and fractures and may lead to secondary conditions such as diabetes,

cardiovascular disease, and osteoporosis, making early detection critically important.
It is also associated with functional decline and rising healthcare and caregiving costs,

highlighting the urgent need for early screening and assessment.

In an aging society,

early detection of sarcopenia is essential.

Increased risk of falls and fractures

Higher risk of complications

Rising healthcare and caregiving burden

EXOMED-DeepSARC

Innovation in Sarcopenia Diagnosis

3 Minute Testing Process

A simple protocol enables sarcopenia diagnostic assessment in approximately three minutes, improving operational efficiency.

Simple, Single-Test Procedure

Enhance real-world usability by streamlining complex, labor-intensive examination procedures.

AI-Based Quantitative Metrics

AI analysis minimizes inter-examiner variability and contextual influences, providing consistent and objective quantitative results.

Expanded Accessibility to Assessment

Designed to enable evaluation even for patients with limited mobility or those difficult to assess using conventional methods, thereby improving access to assessment.

Summary Report for Clinician–Patient Communication

Trust begins with evidence.

We build credibility through evidence-based research and validation.

Patents

Scientific Publications

CES Innovation Award
Minister of Science and ICT Award

NET Certification

Designation as an Innovative Medical Device